Cited 0 times in
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:03:23Z | - |
dc.date.available | 2023-06-02T01:03:23Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194617 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | T.S.K. Mok | - |
dc.contributor.googleauthor | K. Nakagawa | - |
dc.contributor.googleauthor | K. Park | - |
dc.contributor.googleauthor | Y. Ohe | - |
dc.contributor.googleauthor | N. Girard | - |
dc.contributor.googleauthor | H.R. Kim | - |
dc.contributor.googleauthor | Y-L. Wu | - |
dc.contributor.googleauthor | J. Gainor | - |
dc.contributor.googleauthor | S-H. Lee | - |
dc.contributor.googleauthor | C-H. Chiu | - |
dc.contributor.googleauthor | K. Sang-We | - |
dc.contributor.googleauthor | Y. Cheng-Ta | - |
dc.contributor.googleauthor | W. Liang | - |
dc.contributor.googleauthor | L. Wu | - |
dc.contributor.googleauthor | M-C. Lin | - |
dc.contributor.googleauthor | J. Samol | - |
dc.contributor.googleauthor | X. Zhang | - |
dc.contributor.googleauthor | J. Sylvester | - |
dc.contributor.googleauthor | S. Li | - |
dc.contributor.googleauthor | J.C-H. Yang | - |
dc.identifier.doi | 10.1016/j.annonc.2022.10.350 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422045410 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 9 | - |
dc.citation.startPage | S1561 | - |
dc.citation.endPage | S1562 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1561-S1562, 2022-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.